Changes in Tumorigenesis- and Angiogenesis-related Gene Transcript Abundance Profiles in Ovarian Cancer Detected by Tailored High Density cDNA Arrays

Molecular Medicine

Volumn 6, Issue 9, 2000, Pages 750-765

  Martoglio, Ann Marie ^a   Tom, Brian D M ^a   Starkey, Michael ^b   Corps, Anthony N ^a   Charnock Jones, D Stephen ^a   Smith, Stephen K ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Agreement Outliers; Cofilin; Human Placental Lactogen; Neuron restrictive Silencer Factor; Vascular Endothelial Growth Factor (VEGF)

Indexed keywords

COMPLEMENTARY DNA; DNA; MESSENGER RNA; RNA; TUMOR MARKER;

ARTICLE; BIOSYNTHESIS; COMPARATIVE STUDY; DNA MICROARRAY; DNA PROBE; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; METHODOLOGY; NEOVASCULARIZATION (PATHOLOGY); NORTHERN BLOTTING; NUCLEIC ACID HYBRIDIZATION; OVARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULARIZATION;

BLOTTING, NORTHERN; DNA PROBES; DNA, COMPLEMENTARY; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL;

MLCS; MLOWN;

EID: 0034279330     PISSN: 10761551     EISSN: 15283658     Source Type: Journal    
DOI: 10.1007/BF03402191     Document Type: Article

References (105)

1. L.H. Augenlicht M.Z. Wahrman H. Halsey L. Anderson J. Taylor M. Linkin Expression of cloned sequences in biopsies of human colonic tissue and in colonic carcinoma cells induced to differentiate in vitro Cancer Res. 1987 47 6017 6021 1:CAS:528:DyaL1cXhsV2l 3664505
2. L.H. Augenlicht J. Taylor L. Anderson M. Linkin Patterns of gene expression that characterize the colonic mucosa in patients at genetic risk for colonic cancer Proc. Natl. Acad. Sci. U.S.A. 1991 88 3286 3289 1:STN:280:DyaK3M7psFegtw%3D%3D 1849648 51431 10.1073/pnas.88.8.3286
3. D. Pinkel R. Segraves D. Sudar et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays Nat. Genet. 1998 20 207 211 1:CAS:528:DyaK1cXms1eis7s%3D 9771718 10.1038/2524
4. J.L. DeRisi V.R. Iyer P.O. Brown Exploring the metabolic and genetic control of gene expression on a genomic scale Science 1997 278 680 686 1:CAS:528:DyaK2sXmvVynsrs%3D 9381177 10.1126/science.278.5338.680
5. M. Schena D. Shalon R.W. Davis P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 1995 270 467 470 1:CAS:528:DyaK2MXovVersLk%3D 7569999 10.1126/science.270.5235.467
6. G. Ramsay DNA chips: state-of-the art Nat. Biotechnol. 1998 16 40 44 1:CAS:528:DyaK1cXjsVygug%3D%3D 9447591 10.1038/nbt0198-40
7. A. Marshall J. Hodgson DNA chips: an array of possibilities Nat. Biotechnol. 1998 16 27 31 1:CAS:528:DyaK1cXjsVOqsQ%3D%3D 9447589 10.1038/nbt0198-27
8. Y. Chen E.R. Dougherty M.L. Bittner Biomedical Optics 1997 2 364 374 1:CAS:528:DyaK2sXnslyjt74%3D 23014960 10.1117/12.281504
9. F. Bertucci K. Bernard B. Loriod et al. Sensitivity issues in DNA array-based expression measurements and performance of nylon microarrays for small samples Hum. Mol. Genet. 1999 8 1715 1722 1:CAS:528:DyaK1MXmt1ans7g%3D 10441335 10.1093/hmg/8.9.1715
10. R. Higuchi B. Krummel R.K. Saiki A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions Nucleic Acids Res. 1988 16 7351 7367 1:CAS:528:DyaL1cXls1Cqu74%3D 3045756 338413 10.1093/nar/16.15.7351
11. K. Bernard N. Auphan S. Granjeaud et al. Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation Nucleic Acids Res. 1996 24 1435 1442 1:CAS:528:DyaK28Xis1SmsLs%3D 8628675 145825 10.1093/nar/24.8.1435
12. J.M. Bland D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1986 1 307 310 1:STN:280:DyaL287hslWqsQ%3D%3D 2868172 10.1016/S0140-6736(86)90837-8
13. International Organisation for Standardization. (1986) ISO 5725 1986-09-15. Precision of Test Methods
14. T.M. Gress J.D. Hoheisel G.G. Lennon G. Zehetner H. Lehrach Hybridization fingerprinting of high-density cDNA-library arrays with cDNA pools derived from whole tissues Mamm. Genome. 1992 3 609 619 1:CAS:528:DyaK3sXnsVCgtQ%3D%3D 1450511 10.1007/BF00352477
15. C. Nguyen D. Rocha S. Granjeaud et al. Differential gene expression in the murine thymus assayed by quantitative hybridization of arrayed cDNA clones Genomics 1995 29 207 216 1:CAS:528:DyaK2MXotF2hurY%3D 8530073 10.1006/geno.1995.1233
16. D. Gerhold T. Rushmore C.T. Caskey DNA chips: promising toys have become powerful tools Trends Biochem. Sci. 1999 24 168 173 1:CAS:528:DyaK1MXkslSnsbo%3D 10322428 10.1016/S0968-0004(99)01382-1
17. N. Zhao H. Hashida N. Takahashi Y. Misumi Y. Sakaki High-density cDNA filter analysis: a novel approach for large-scale, quantitative analysis of gene expression Gene 1995 156 207 213 1:CAS:528:DyaK2MXlslGqtL4%3D 7758958 10.1016/0378-1119(95)00023-Y
18. D. Rabinerson B. Kaplan H. Levavi A. Neri The biology of ovarian cancer of epithelial origin Isr. J. Med. Sci. 1996 32 1128 1133 1:STN:280:DyaK2s7hvFaltA%3D%3D 8960089
19. A.M. Westermann J.H. Bijnen W.H. Moolenaar S. Rodenhuis Growth factors in human ovarian cancer Cancer Treat. Rev. 1997 23 113 131 1:CAS:528:DyaK2sXltVCjtLg%3D 9225962 10.1016/S0305-7372(97)90024-4
20. J. Wimalasena R. Dostal D. Meehan Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth Gynecol. Oncol. 1992 46 345 350 1:STN:280:DyaK38vgs1Sktw%3D%3D 1326473 10.1016/0090-8258(92)90230-G
21. J.H. Kim M.M. Seibel D.T. MacLaughlin et al. The inhibitory effects of mullerian-inhibiting substance on epidermal growth factor induced proliferation and progesterone production of human granulosa-luteal cells J. Clin. Endocrinol. Metab. 1992 75 911 917 1:CAS:528:DyaK38XmtVGnurw%3D 1517385
22. S. Kooi H.Z. Zhang R. Patenia C.L. Edwards C.D. Platsoucas R.S. Freedman HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2 Cell Immunol. 1996 174 116 128 1:CAS:528:DyaK28XnsF2itrY%3D 8954611 10.1006/cimm.1996.0301
23. A.E. Loercher M.A. Nash J.J. Kavanagh C.D. Platsoucas R.S. Freedman Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells J. Immunol. 1999 163 6251 6260 1:CAS:528:DyaK1MXns12rtL8%3D 10570318
24. E.D. Zanders M.G. Goulden T.C. Kennedy K.E. Kempsell Analysis of immune system gene expression in small rheumatoid arthritis biopsies using a combination of subtractive hybridization and high-density cDNA arrays J. Immunol. Methods 2000 233 131 140 1:CAS:528:DC%2BD3cXltVejtA%3D%3D 10648863 10.1016/S0022-1759(99)00126-X
25. J. Dietl H.P. Horny P. Ruck E. Kaiserling Dysgerminoma of the ovary. An immunohistochemical study of tumor-infiltrating lymphoreticular cells and tumor cells Cancer 1993 71 2562 2568 1:STN:280:DyaK3s3gtFCrsQ%3D%3D 8453580 10.1002/1097-0142(19930415)71:8<2562::AID-CNCR2820710821>3.0.CO;2-E
26. F.G. Snijdewint S. von Mensdorff-Pouilly A.H. Karuntu-Wanamarta et al. Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls Cancer Immunol. Immunother. 1999 48 47 55 1:STN:280:DyaK1M3kvFGltQ%3D%3D 10235488 10.1007/s002620050547
27. E.R. Richards P.L. Devine R.J. Quin J.D. Fontenot B.G. Ward M.A. McGuckin Antibodies reactive with the protein core of MUC1 mucin are present in ovarian cancer patients and healthy women Cancer Immunol. Immunother. 1998 46 245 252 1:CAS:528:DyaK1cXmt1ertLw%3D 9690452 10.1007/s002620050484
28. J. Taylor-Papadimitriou J. Burchell D.W. Miles M. Dalziel MUC1 and cancer Biochim. Biophys. Acta. 1999 1455 301 313 1:CAS:528:DyaK1MXntlOhu7c%3D 10571020 10.1016/S0925-4439(99)00055-1
29. P.M. Comoglio C. Boccaccio The HGF receptor family: unconventional signal transducers for invasive cell growth Genes Cells. 1996 1 347 354 1:CAS:528:DyaK28XksFChsbY%3D 9135079 10.1046/j.1365-2443.1996.37037.x
30. S. Fracchioli D. Katsaros P. Maggiora M.F. Di Renzo M. Massobrio Evaluation of Ron and Met proto-oncogene expression in epithelial ovarian tumors Minerva Ginecol. 1999 51 359 364 1:STN:280:DC%2BD3c7gtlGitw%3D%3D 10638160
31. D. Marx C. Binder H. Meden et al. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer Anticancer Res. 1997 17 2233 2240 1:CAS:528:DyaK2sXkvFylsbs%3D 9216694
32. T. Strobel Y.T. Tai S. Korsmeyer S.A. Cannistra BAD partly reverses paclitaxel resistance in human ovarian cancer cells Oncogene 1998 17 2419 2427 1:CAS:528:DyaK1cXnvVejtbg%3D 9824152 10.1038/sj.onc.1202180
33. M.J. Pishvaian C.M. Feltes P. Thompson M.J. Bussemakers J.A. Schalken S.W. Byers Cadherin-11 is expressed in invasive breast cancer cell lines Cancer Res. 1999 59 947 952 1:CAS:528:DyaK1MXht1Smsbw%3D 10029089
34. C. Barletta D. Lazzaro R. Prosperi Porta et al. C-MYB activation and the pathogenesis of ovarian cancer Eur. J. Gynaecol. Oncol. 1992 13 53 59 1:STN:280:DyaK387pt1Smtw%3D%3D 1547794
35. N. Keshava S. Gubba R.R. Tekmal Overexpression of macrophage colony-stimulating factor (CSF-1) and its receptor, c-fms, in normal ovarian granulosa cells leads to cell proliferation and tumorigenesis J. Soc. Gynecol. Investig. 1999 6 41 49 1:CAS:528:DyaK1MXhsFSisrc%3D 10065425
36. K. Terashi M. Oka S. Ohdo et al. Close association between clearance of recombinant human granulocyte colony-stimulating factor (G-CSF) and G-CSF receptor on neutrophils in cancer patients Antimicrob. Agents Chemother. 1999 43 21 24 1:CAS:528:DyaK1MXpvFGgsg%3D%3D 9869559 89014 10.1093/jac/43.suppl_3.21
37. M. Inoue S. Kyo M. Fujita T. Enomoto G. Kondoh Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors Cancer Res. 1994 54 3049 3053 1:CAS:528:DyaK2cXktVKgtLg%3D 7514496
38. L.K. Ashman The biology of stem cell factor and its receptor C-kit. Int J. Biochem. Cell. Biol. 1999 31 1037 1051 1:CAS:528:DyaK1MXmsVWitrY%3D 10.1016/S1357-2725(99)00076-X
39. T. Nakata K. Suzuki J. Fujii et al. High expression of manganese superoxide dismutase in 7,12-dimethylbenz[a]anthracene-induced ovarian cancer and increased serum levels in the tumor-bearing rats Carcinogenesis 1992 13 1941 1943 1:CAS:528:DyaK38XmsV2gsLY%3D 1423860 10.1093/carcin/13.10.1941
40. T. Nishida T. Sugiyama A. Kataoka M. Tashiro M. Yakushiji M. Ishikawa Serum manganese superoxide dismutase (MnSOD) and histological virulence of ovarian cancer Asia Oceania J. Obstet. Gynaecol. 1993 19 427 431 1:STN:280:DyaK2c7otlSrtA%3D%3D 8135676 10.1111/j.1447-0756.1993.tb00403.x
41. J. McLaren A. Prentice D.S. Charnock-Jones et al. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids J. Clin. Invest. 1996 98 482 489 1:CAS:528:DyaK28XksFCltrY%3D 8755660 507453 10.1172/JCI118815
42. M. Orre P.A. Rogers Macrophages and microvessel density in tumors of the ovary Gynecol. Oncol. 1999 73 47 50 1:STN:280:DyaK1M7pslSisw%3D%3D 10094879 10.1006/gyno.1998.5292
43. R.D. Leek N.C. Hunt R.J. Landers C.E. Lewis J.A. Royds A.L. Harris Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer J. Pathol. 2000 190 430 436 1:CAS:528:DC%2BD3cXisF2rtr0%3D 10699991 10.1002/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6
44. P. Maggiora S. Marchio M.C. Stella et al. Overexpression of the RON gene in human breast carcinoma Oncogene 1998 16 2927 2933 1:CAS:528:DyaK1cXjvFSjuro%3D 9671413 10.1038/sj.onc.1201812
45. B. Bottazzi P. Ghezzi G. Taraboletti et al. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues Int. J. Cancer. 1985 36 167 173 1:CAS:528:DyaL2MXltVehtLs%3D 4018909 10.1002/ijc.2910360207
46. E. Zavadova A. Loercher S. Verstovsek C.F. Verschraegen M. Micksche R.S. Freedman The role of macrophages in antitumor defense of patients with ovarian cancer Hematol. Oncol. Clin. North Am. 1999 13 135 144 1:STN:280:DyaK1M7nvFyjuw%3D%3D 10080073 10.1016/S0889-8588(05)70157-X
47. A. Bagnato R. Tecce C. Moretti V. Di Castro D. Spergel K.J. Catt Autocrine actions of endothelin-1 as a growth factor in human ovarian carcinoma cells Clin. Cancer Res. 1995 1 1059 1066 1:CAS:528:DyaK2MXoslSmtL4%3D 9816080
48. A. Bagnato D. Salani V. Di Castro et al. Expression of endothelin 1 and endothelin A receptor in ovarian carcinoma: evidence for an autocrine role in tumor growth Cancer Res. 1999 59 720 727 1:CAS:528:DyaK1MXhtFSisbo%3D 9973223
49. J. Eberle S. Weitmann O. Thieck H. Pech M. Paul C.E. Orfanos Downregulation of endothelin B receptor in human melanoma cell lines parallel to differentiation genes J. Invest. Dermatol. 1999 112 925 932 1:CAS:528:DyaK1MXktVSjsbo%3D 10383740 10.1046/j.1523-1747.1999.00598.x
50. D. Hanahan R.A. Weinberg The hallmarks of cancer Cell 2000 100 57 70 1:CAS:528:DC%2BD3cXks1CktA%3D%3D 10647931 10.1016/S0092-8674(00)81683-9
51. I.J. Fidler L.M. Ellis The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 1994 79 185 188 1:CAS:528:DyaK2cXmslOltLY%3D 7525076 10.1016/0092-8674(94)90187-2
52. J. Folkman K. Watson D. Ingber D. Hanahan Induction of angiogenesis during the transition from hyperplasia to neoplasia Nature 1989 339 58 61 1:STN:280:DyaL1M3jvVGntg%3D%3D 2469964 10.1038/339058a0
53. L.A. Liotta J. Kleinerman G.M. Saidel Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation Cancer Res. 1974 34 997 1004 1:STN:280:DyaE2c3nsVamsg%3D%3D 4841969
54. J. Folkman What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 1990 82 4 6 1:STN:280:DyaK3c%2FnvF2qug%3D%3D 1688381 10.1093/jnci/82.1.4
55. N. Bouck V. Stellmach S.C. Hsu How tumors become angiogenic Adv. Cancer Res. 1996 69 135 174 1:CAS:528:DyaK28XlvFWiu74%3D 8791681 10.1016/S0065-230X(08)60862-3
56. J. Folkman J.F. Holland R.C. Bast D.L. Morton E. Frei D.W. Kufte Weichselbaum Tumor angiogenesis Cancer Medicine 1997 Baltimore Williams and Wilkins 181 204
57. D. Hanahan J. Folkman Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis Cell 1996 86 353 364 1:CAS:528:DyaK28XltVSks7s%3D 8756718 10.1016/S0092-8674(00)80108-7
58. H.M. Sowter A.N. Corps A.L. Evans D.E. Clark D.S. Charnock-Jones S.K. Smith Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors Lab. Invest. 1997 77 607 614 1:CAS:528:DyaK1cXkvVGjug%3D%3D 9426398
59. A.D. Santin P.L. Hermonat A. Ravaggi M.J. Cannon S. Pecorelli G.P. Parham Secretion of vascular endothelial growth factor in ovarian cancer Eur. J. Gynaecol. Oncol. 1999 20 177 181 1:STN:280:DyaK1Mzjs1Klsg%3D%3D 10410879
60. C.A. Boocock D.S. Charnock-Jones A.M. Sharkey et al. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma J. Natl. Cancer Inst. 1995 87 506 516 1:CAS:528:DyaK2MXlsVequrc%3D 7707437 10.1093/jnci/87.7.506
61. M. Orre P.A. Rogers VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumors of the ovary Int. J. Cancer 1999 84 101 108 1:STN:280:DyaK1M7ptl2jsQ%3D%3D 10096239 10.1002/(SICI)1097-0215(19990420)84:2<101::AID-IJC2>3.0.CO;2-5
62. G.M. Abu-Jawdeh J.D. Faix J. Niloff et al. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms Lab. Invest. 1996 74 1105 1115 1:STN:280:DyaK283kvFWiug%3D%3D 8667614
63. D.E. Clark S.K. Smith Y. He et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation Biol. Reprod. 1998 59 1540 1548 1:CAS:528:DyaK1cXnvVOgs7k%3D 9828203 10.1095/biolreprod59.6.1540
64. K.E. de Visser W.M. Kast Effects of TGF-β on the immune system: implications for cancer immunotherapy Leukemia 1999 13 1188 1199 10450746 10.1038/sj.leu.2401477 1:CAS:528:DyaK1MXlvVOiuro%3D
65. H. Saito S. Tsujitani S. Oka A. Kondo M. Ikeguchi M. Maeta N. Kaibara The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma Cancer 1999 86 1455 1462 1:CAS:528:DyaK1MXntlSkur0%3D 10526273 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L
66. R.E. Bristow R.L. Baldwin S.D. Yamada M. Korc B.Y. Karlan Altered expression of transforming growth factor-β ligands and receptors in primary and recurrent ovarian carcinoma Cancer 1999 85 658 668 1:STN:280:DyaK1M7ptVWlsg%3D%3D 10091739 10.1002/(SICI)1097-0142(19990201)85:3<658::AID-CNCR16>3.0.CO;2-M
67. A. Stratmann W. Risau K.H. Plate Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis Am. J. Pathol. 1998 153 1459 1466 1:CAS:528:DyaK1cXns1Ohu7Y%3D 9811337 1853417 10.1016/S0002-9440(10)65733-1
68. G. Thurston C. Suri K. Smith et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1 Science 1999 286 2511 2514 1:CAS:528:DC%2BD3cXntlan 10617467 10.1126/science.286.5449.2511
69. N. Sheibani W.A. Frazier Thrombospondin 1 expression in transformed endothelial cells restores a normal phenotype and suppresses their tumorigenesis Proc. Natl. Acad. Sci. U.S.A. 1995 92 6788 6792 1:CAS:528:DyaK2MXntVSks7k%3D 7624320 41414 10.1073/pnas.92.15.6788
70. M.L. Iruela-Arispe F. Vazquez M.A. Ortega Antiangiogenic domains shared by thrombospondins and metallospondins, a new family of angiogenic inhibitors Ann. NY Acad. Sci. 1999 886 58 66 1:CAS:528:DC%2BD3cXnt1eitQ%3D%3D 10667203 10.1111/j.1749-6632.1999.tb09400.x
71. P. Bagavandoss P. Kaytes G. Vogeli P.A. Wells J.W. Wilks Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro Biochem. Biophys. Res. Commun. 1993 192 325 332 1:CAS:528:DyaK3sXisFaisrg%3D 8484744 10.1006/bbrc.1993.1418
72. F.E. Nathan E. Hernandez C.J. Dunton et al. Plasma thrombospondin levels in patients with gynecologic malignancies Cancer 1994 73 2853 2858 1:STN:280:DyaK2c3ltFOhug%3D%3D 8194026 10.1002/1097-0142(19940601)73:11<2853::AID-CNCR2820731131>3.0.CO;2-9
73. G. Oshiba H. Kijima S. Himeno et al. Stromal thrombospondin-1 expression is correlated with progression of esophageal squamous cell carcinomas Anticancer Res. 1999 19 4375 4378 1:STN:280:DC%2BD3c7hs1Gmuw%3D%3D 10650779
74. Q.X. Sang Complex role of matrix metalloproteinases in angiogenesis Cell Res. 1998 8 171 177 1:STN:280:DyaK1M%2Fgsl2nsA%3D%3D 9791730 10.1038/cr.1998.17
75. N. Ferrara T. Davis-Smyth The biology of vascular endothelial growth factor Endocr. Rev. 1997 18 4 25 1:CAS:528:DyaK2sXhsFCiu7s%3D 9034784 10.1210/edrv.18.1.0287
76. J. Folkman P.A. D’Amore Blood vessel formation: what is its molecular basis? Cell 1996 87 1153 1155 1:CAS:528:DyaK2sXit1ClsA%3D%3D 8980221 10.1016/S0092-8674(00)81810-3
77. D. Hanahan Signaling vascular morphogenesis and maintenance Science 1997 277 48 50 1:CAS:528:DyaK2sXksVyhtrk%3D 9229772 10.1126/science.277.5322.48
78. N.W. Gale G.D. Yancopoulos Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development Genes Dev. 1999 13 1055 1066 1:CAS:528:DyaK1MXjt1yiurk%3D 10323857 10.1101/gad.13.9.1055
79. D. Shweiki M. Neeman A. Itin E. Keshet Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis Proc. Natl. Acad. Sci. USA 1995 92 768 772 1:CAS:528:DyaK2MXjsVKitbk%3D 7531342 10.1073/pnas.92.3.768 42701
80. N. Ferrara Molecular and biological properties of vascular endothelial growth factor J. Mol. Med. 1999 77 527 543 1:CAS:528:DyaK1MXmsFOiurY%3D 10494799 10.1007/s001099900019
81. P.C. Maisonpierre C. Suri P.F. Jones et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 1997 277 55 60 1:CAS:528:DyaK2sXksVyhu78%3D 9204896 10.1126/science.277.5322.55
82. S. Davis T.H. Aldrich P.F. Jones et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning Cell 1996 87 1161 1169 1:CAS:528:DyaK2sXit1Cqsw%3D%3D 8980223 10.1016/S0092-8674(00)81812-7
83. J. Holash P.C. Maisonpierre D. Compton et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF Science 1999 284 1994 1998 1:CAS:528:DyaK1MXktVWntrY%3D 10373119 10.1126/science.284.5422.1994
84. J. Holash S.J. Wiegand G.D. Yancopoulos New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF Oncogene 1999 18 5356 5362 1:CAS:528:DyaK1MXms1Ontr0%3D 10498889 10.1038/sj.onc.1203035
85. E. Nishimura K. Sasaki K. Maruyama T. Tsukada K. Yamaguchi Decrease in neuronrestrictive silencer factor (NRSF) mRNA levels during differentiation of cultured neuroblastoma cells Neurosci. Lett. 1996 211 101 104 1:CAS:528:DyaK28XktVSnsro%3D 8830854 10.1016/0304-3940(96)12722-1
86. J.M. Coulson C.E. Fiskerstrand P.J. Woll J.P. Quinn Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer Cancer Res. 1999 59 5123 5127 1:CAS:528:DyaK1MXmvFels78%3D 10537286
87. K.K. Au E. Liong J.Y. Li et al. Increases in mRNA levels of glucose transporters types 1 and 3 in Ehrlich ascites tumor cells during tumor development J. Cell. Biochem. 1997 67 131 135 1:CAS:528:DyaK2sXmvFCmtLc%3D 9328846 10.1002/(SICI)1097-4644(19971001)67:1<131::AID-JCB13>3.0.CO;2-K
88. P.E. North M. Waner A. Mizeracki M.C. Mihm GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas Hum. Pathol. 2000 31 11 22 1:CAS:528:DC%2BD3cXptVegtw%3D%3D 10665907 10.1016/S0046-8177(00)80192-6
89. J. Huang M. Gu C. Chen Expression of glutathione S-transferase-pi in operative specimens as marker of chemoresistance in patients with ovarian cancer Chung Hua Fu Chan Ko Tsa Chih. 1997 32 458 461 1:STN:280:DyaK1czgtlyltg%3D%3D 9639737
90. T. Ichikawa J. Masumoto M. Kaneko T. Saida J. Sagara S. Taniguchi Moesin and CD44 expression in cutaneous melanocytic tumors Br. J. Dermatol. 1998 138 763 768 1:STN:280:DyaK1czjtFCgtA%3D%3D 9666819 10.1046/j.1365-2133.1998.02255.x
91. Y. Samstag C. Eckerskorn S. Wesselborg S. Henning R. Wallich S.C. Meuer Costimulatory signals for human T-cell activation induce nuclear translocation of pp19/cofilin Proc. Natl. Acad. Sci. USA 1994 91 4494 4498 1:CAS:528:DyaK2cXkvVSmsrY%3D 8183936 10.1073/pnas.91.10.4494 43812
92. Y. Samstag E.M. Dreizler A. Ambach G. Sczakiel S.C. Meuer Inhibition of constitutive serine phosphatase activity in T lymphoma cells results in phosphorylation of pp19/cofilin and induces apoptosis J. Immunol. 1996 156 4167 4173 1:CAS:528:DyaK28XjtFCntbo%3D 8666784
93. P. Sinha G. Hutter E. Kottgen M. Dietel D. Schadendorf H. Lage Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas Electrophoresis 1999 20 2952 2960 1:CAS:528:DyaK1MXmvFahtrg%3D 10546833 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H
94. C.A. Stanyon O. Bernard LIM-kinase1 Int. J. Biochem. Cell Biol. 1999 31 389 394 1:CAS:528:DyaK1MXitleisbY%3D 10224665 10.1016/S1357-2725(98)00116-2
95. Y. Shimoyama M. Gotoh T. Terasaki M. Kitajima S. Hirohashi Isolation and sequence analysis of human cadherin-6 complementary DNA for the full coding sequence and its expression in human carcinoma cells Cancer Res. 1995 55 2206 2211 1:CAS:528:DyaK2MXls1OksL0%3D 7743525
96. T. Shimazui E. Oosterwijk H. Akaza et al. Expression of cadherin-6 as a novel diagnostic tool to predict prognosis of patients with E-cadherin-absent renal cell carcinoma Clin. Cancer Res. 1998 4 2419 2424 1:CAS:528:DyaK1cXmvFyktb0%3D 9796973
97. M.J. Bussemakers A. Van Bokhoven K. Tomita C.F. Jansen J.A. Schalken Complex cadherin expression in human prostate cancer cells Int. J. Cancer 2000 85 446 450 1:CAS:528:DC%2BD3cXmsVCntg%3D%3D 10652439 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.0.CO;2-B
98. M. Maekawa T. Ishizaki S. Boku et al. Signaling from Rho to the actin cytoskeleton through protein kinases ROCK and LIM-kinase Science 1999 285 895 898 1:CAS:528:DyaK1MXltVels7k%3D 10436159 10.1126/science.285.5429.895
99. S. Narumiya Cellular functions & pharmacological manipulations of the small GTPase Rho & Rho effectors Nippon Yakurigaku Zassh. 1999 114 Suppl 1 P 5P
100. C.I. Dax F. Lottspeich S. Mullner In vitro model system for the identification and characterization of proteins involved in inflammatory processes Electrophoresis 1998 19 1841 1847 1:STN:280:DyaK1czosVSksQ%3D%3D 9719568 10.1002/elps.1150191049
101. K. Wang L. Gan E. Jeffery et al. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray Gene 1999 229 101 108 1:CAS:528:DyaK1MXit1Kms7s%3D 10095109 10.1016/S0378-1119(99)00035-9
102. A.G. Hall Glutathione and the regulation of cell death Adv. Exp. Med. Biol. 1999 457 199 203 1:CAS:528:DC%2BD3cXis1Citrw%3D 10500794 10.1007/978-1-4615-4811-9_21
103. J.M. Sargent C. Williamson A.G. Hall A.W. Elgie C.G. Taylor Evidence for the involvement of the glutathione pathway in drug resistance in AML Adv. Exp. Med. Biol. 1999 457 205 209 1:CAS:528:DC%2BD3cXis1Citr0%3D 10500795 10.1007/978-1-4615-4811-9_22
104. H. Shiga E.I. Heath A.A. Rasmussen et al. Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer Clin. Cancer Res. 1999 5 4097 4104 1:CAS:528:DC%2BD3cXlsV2gsg%3D%3D 10632346
105. J.K. Horton G. Roy J.T. Piper et al. Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu Biochem. Pharmacol. 1999 58 693 702 1:CAS:528:DyaK1MXks1Wrsb0%3D 10413308 10.1016/S0006-2952(99)00142-2